Zobrazeno 1 - 10
of 188
pro vyhledávání: '"Hisashi MATSUSHIMA"'
Autor:
Keina Nozaki, Hisashi Matsushima, Hiyo Obikane, Ryohei Nishimoto, Ryo Tanaka, Takeru Morishige, Tomoko Masuda, Haruki Kume
Publikováno v:
IJU Case Reports, Vol 6, Iss 6, Pp 329-333 (2023)
Introduction Disseminated carcinomatosis of the bone marrow in prostate cancer is rare and has a poor prognosis. Although strong evidence suggests that novel hormonal agents improve the prognosis of metastatic prostate cancer, their effectiveness in
Externí odkaz:
https://doaj.org/article/7ca780e084694444b0e26f409f5c5956
Autor:
Yirong Chen, Kazuki Kobayashi, Shikha Singh, Hiroji Uemura, Hisashi Matsushima, Akira Yokomizo, Gaku Arai, Takefumi Satoh, Vince Grillo, Dianne Athene Ledesma
Publikováno v:
BMJ Open, Vol 11, Iss 8 (2021)
Objectives With novel antiandrogen treatments of varying clinical benefits and risks becoming available, this study investigates how patients with castration-resistant prostate cancer (CRPC) value differences in treatment characteristics.Design Cross
Externí odkaz:
https://doaj.org/article/b5fc961dcbd0411eab0aaaafe50ca443
Autor:
Yousuke Gomi, Liangcheng Wang, Hisashi Matsushima, Ayaka Kawabe, Atsuko Kikugawa, Akiyoshi Takagi, Kenichi Kuromaki
Publikováno v:
Taiwanese Journal of Obstetrics & Gynecology, Vol 58, Iss 6, Pp 805-807 (2019)
Objective: To investigate the long-term antibiotic susceptibility of group B Streptococcus (GBS) present in the vagina. Materials and methods: A population-based retrospective cohort study was performed. A total of 19,899 women who underwent vaginal
Externí odkaz:
https://doaj.org/article/8139d6c1d4e84e7a8f1bfc2477230527
Autor:
Yuji Hakozaki, Hisashi Matsushima, Jimpei Kumagai, Taro Murata, Tomoko Masuda, Yoko Hirai, Mai Oda, Nobuo Kawauchi, Munehiro Yokoyama, Yukio Homma
Publikováno v:
BMC Urology, Vol 17, Iss 1, Pp 1-6 (2017)
Abstract Background This study compared the detection rates for clinically significant prostate cancer (CSPC) between magnetic resonance imaging and ultrasonography (MRI/US)-fusion-targeted biopsy (TB), systematic biopsy (SB) and combination of TB an
Externí odkaz:
https://doaj.org/article/d96396823da146dbac3499f595cca262
Autor:
Yuji Hakozaki, Taro Murata, Munehiro Yokoyama, Hisashi Matsushima, Maki Ogawa, Tomoko Masuda, Yoko Hirai, Haruki Kume
Publikováno v:
Urology Case Reports, Vol 20, Iss , Pp 67-69 (2018)
We report a case with prostate cancer and gastric neuroendocrine carcinoma. A 72-year old male presented with a gastric lesion 5 months after radical prostatectomy. The lesion was immunohistochemically positive for PSA, alpha-methylacyl-CoA racemase,
Externí odkaz:
https://doaj.org/article/87a33e0af86f4b62b975b58e11cbe415
Autor:
Hisashi Matsushima, Yasuko Kaneko, Kimie Atsuzawa, Kimie Sakamoto, Mizuki Ajisaka, Tasuku Kamada, Daiki Kanaizumi
Publikováno v:
Microscopy. 69:214-226
The aquatic carnivorous plant Aldrovanda vesiculosa L. is critically endangered worldwide; its peculiar lifestyle raises many questions and poses problems both intriguing on their own and relevant to conservation. While establishing a culture system
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5a4915a3820830e580c42e00feae0ef
https://doi.org/10.1093/jmicro/dfaa019
https://doi.org/10.1093/jmicro/dfaa019
Autor:
Toshitsugu Sugimoto, Tetsuya Taguchi, Toshiyuki Yoneda, Hisashi Matsushima, Toshio Matsumoto, Satoshi Soen, Takashi Ishikawa, Shigeo Horie, Seiji Fukumoto, Masakazu Terauchi
Publikováno v:
Journal of Bone and Mineral Metabolism. 38:141-144
Androgen deprivation therapy and aromatase inhibitors are known to cause a decrease in bone mineral density and an increase in fractures. Patients receiving these treatments have been shown to have a fracture risk equal to or greater than that of pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c729e0a1556a69cbe900bc7850b80374
https://doi.org/10.1007/s00774-020-01087-0
https://doi.org/10.1007/s00774-020-01087-0
Autor:
Osamu Yokoyama, Masashi Honda, Tomonori Yamanishi, Yuki Sekiguchi, Kenji Fujii, Takashi Nakayama, Takao Mogi, Takeya Kitta, Chikara Ohyama, Koichi Kambe, Yoshikatsu Tanahashi, Isoji Sasagawa, Mikinobu Ootani, Eiyu Nozawa, Toshihiko Saito, Fumio Manabe, Yasutomo Suzuki, Hikaru Tomoe, Satoru Takahashi, Nozomu Kawata, Hisashi Matsushima, Taketo Kawai, Manami Kinjo, Takashi Fukagai, Atsuko Takahashi, Fumio Nakajima, Haruaki Sasaki, Norihiko Okuno, Toshiyuki Itoi, Yoshiyuki Ishiura, Atsushi Mizokami, Yosuke Matsuta, Norifumi Sawada, Kosei Miwa, Atsushi Otsuka, Yasuhito Funahashi, Masaki Yoshida, Motoi Tobiume, Akihiro Kawauchi, Hiroshi Okuno, Terukazu Nakamura, Noriko Ninomiya, Chie Matsushita, Atsushi Takenaka, Takeshi Watanabe, Toyohiko Watanabe, Noritaka Ishito, Yasuyo Yamamoto, Hiroshi Ikeda, Narihito Seki, Shigehiro Kanegae, Kenichi Suyama, Kazuyuki Sagiyama, Noriaki Tokuda, Hideki Sakai, Hiroaki Nishimura, Motoshi Kawahara
Publikováno v:
International Journal of Urology
OBJECTIVE To evaluate the efficacy and safety of onabotulinumtoxinA (botulinum toxin type A) 100 U in patients with overactive bladder and urinary incontinence. METHODS This was a phase III, randomized, double-blind, placebo-controlled trial in Japan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5945ddc99d0d90ffd95556e9c059fe0c
https://doi.org/10.1111/iju.14176
https://doi.org/10.1111/iju.14176
Autor:
Gaku Arai, Hisashi Matsushima, Hiroji Uemura, Vince Grillo, Takefumi Satoh, Dianne Athene Ledesma, Akira Yokomizo, Yirong Chen, Shikha Satendra Singh, Kazuki Kobayashi
Publikováno v:
BMJ Open, Vol 11, Iss 8 (2021)
BMJ Open
BMJ Open
ObjectivesWith novel antiandrogen treatments of varying clinical benefits and risks becoming available, this study investigates how patients with castration-resistant prostate cancer (CRPC) value differences in treatment characteristics.DesignCross-s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b69e6b340799af5cf1ea3934ce4b26c
https://bmjopen.bmj.com/content/11/8/e052471.full
https://bmjopen.bmj.com/content/11/8/e052471.full
Autor:
Toni Sarapohja, Neal D. Shore, Mutsushi Kawakita, Hiroya Mizusawa, Marie Aude Le Berre, Matthew R. Smith, Kazuhiro Suzuki, Masahiro Iinuma, Tetsuo Momma, Mototsugu Oya, Kazuki Kobayashi, Teuvo L.J. Tammela, Hiroji Uemura, Amir Snapir, Hirotsugu Uemura, Satoshi Fukasawa, Hisashi Matsushima, Nobuaki Matsubara, Iris Kuss, Ken-ichi Tabata, Tadahiro Kobayashi, Karim Fizazi, Hiroaki Nishimatsu
Publikováno v:
International Journal of Clinical Oncology
Background Darolutamide, an oral androgen receptor inhibitor, has been approved for treating nonmetastatic castration-resistant prostate cancer (nmCRPC), based on significant improvements in metastasis-free survival (MFS) in the ARAMIS clinical trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e6518b45933ebb3931b0d705c800ab1
https://trepo.tuni.fi/handle/10024/128183
https://trepo.tuni.fi/handle/10024/128183
